- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03055728
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Strep pharyngitis, or strep throat, is a common infection afflicting children, aged 2 and above. Testing for strep pharyngitis consists of a rapid test and/or a throat culture. However, it has been observed that rapid testing may not be accurate in children with a recent history of strep pharyngitis. Therefore, this study aims to determine the accuracy of rapid strep testing in children who are presenting with symptoms of strep throat, who also have a recent history of and treatment for strep pharyngitis. By demonstrating an inaccuracy in rapid strep testing in patients with a recent history of strep pharyngitis, unnecessary testing and antibiotic use may be decreased, thereby reducing costs, overuse of antibiotics, and antibiotic resistance.
The participants in the study will include 600 children, aged 2 to 20 years old, selected from a private practice in Northern Virginia who present to the practice with signs or symptoms suggestive of acute pharyngitis. Subjects are children who are presenting with signs and symptoms suggestive of acute pharyngitis by the Centor criteria, including sore throat, fever, abdominal pain and cervical lymphadenitis. Any child with above presenting symptoms who is to undergo Streptococcus rapid antigen testing will be recruited to participate in the study.
A letter of consent will be provided to the parents and guardians of the involved child, stating that the study will be voluntary and confidential, and that all results will be kept in a safe environment.
Investigators will be testing the difference between two proportions, the false positive rate in previously treated compared to those not treated.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Virginia
-
Falls Church, Virginia, United States, 22046
- Northern Virginia Pediatrics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The participants in the study will include 600 children, aged 2 to 20 years old, selected from a private practice in Northern Virginia who present to the practice with signs or symptoms suggestive of acute pharyngitis.
Potential subjects who have been treated with less than 10 days of antibiotic therapy, patients who report non-compliance with previous antibiotic therapy, patients who have already been included in the study and children with evidence of GAS carrier status will be excluded.
Description
Inclusion Criteria:
- 2-20 years old
- Current signs and symptoms suggestive of acute pharyngitis, including sore throat, fever, abdominal pain and cervical lymphadenitis.
Exclusion Criteria:
- Potential subjects who have been treated with less than 10 days of antibiotic therapy
- Patients who report non-compliance with previous antibiotic therapy
- Patients who have already been included in the study and children with evidence of GAS carrier status
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1 / Study Group
Subjects presenting with signs or symptoms of acute pharyngitis, with a history of culture-proven GAS infection and subsequent 10-day antibiotic treatment within the preceding 28 days.
Subjects will have a rapid strep antigen detection test and a throat culture to determine presence of strep.
|
Pharyngeal swab for rapid antigen detection of streptococcus
Other Names:
Pharyngeal swab for culture for bacteria (specifically streptococcus) presence
|
Group 2 / Control Group
Subjects presenting with signs or symptoms of acute pharyngitis, without a recent history of GAS infection.
Subjects will have a rapid strep antigen detection test and a throat culture to determine presence of strep.
|
Pharyngeal swab for rapid antigen detection of streptococcus
Other Names:
Pharyngeal swab for culture for bacteria (specifically streptococcus) presence
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of false positives and false negatives in rapid antigen testing compared to throat culture
Time Frame: 48-72 hours
|
The primary objective is to use rapid antigen test results to compare the sensitivity and specificity of rapid antigen testing in children with symptoms of pharyngitis with and without a recent history of Group A streptococcus pharyngitis.
|
48-72 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amin Barakat, MD, Georgetown University Hospital
Publications and helpful links
General Publications
- Sheeler RD, Houston MS, Radke S, Dale JC, Adamson SC. Accuracy of rapid strep testing in patients who have had recent streptococcal pharyngitis. J Am Board Fam Pract. 2002 Jul-Aug;15(4):261-5.
- Edmonson MB, Farwell KR. Relationship between the clinical likelihood of group a streptococcal pharyngitis and the sensitivity of a rapid antigen-detection test in a pediatric practice. Pediatrics. 2005 Feb;115(2):280-5. doi: 10.1542/peds.2004-0907.
- McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13;158(1):75-83.
- Llor C, Calvino O, Hernandez S, Crispi S, Perez-Bauer M, Fernandez Y, Martinez T, Gomez FF, Cots JM. Repetition of the rapid antigen test in initially negative supposed streptococcal pharyngitis is not necessary in adults. Int J Clin Pract. 2009 Sep;63(9):1340-4. doi: 10.1111/j.1742-1241.2009.02048.x.
- Leung AK, Newman R, Kumar A, Davies HD. Rapid antigen detection testing in diagnosing group A beta-hemolytic streptococcal pharyngitis. Expert Rev Mol Diagn. 2006 Sep;6(5):761-6. doi: 10.1586/14737159.6.5.761.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-0388
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Streptococcal Infections
-
GlaxoSmithKlineCompletedInfections, StreptococcalPoland, Philippines
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfections, StreptococcalJapan
-
GlaxoSmithKlineCompletedInfections, StreptococcalNetherlands
-
GlaxoSmithKlineCompletedInfections, StreptococcalFinland
-
GlaxoSmithKlineCompletedInfections, StreptococcalMali
-
GlaxoSmithKlineCompletedInfections, StreptococcalKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, StreptococcalSlovakia, Sweden, Denmark, Norway
-
GlaxoSmithKlineCompletedInfections, StreptococcalSlovakia, Sweden
-
GlaxoSmithKlineCompletedInfections, StreptococcalFinland, France, Poland
Clinical Trials on Rapid strep antigen detection test
-
Foundation for Innovative New Diagnostics, SwitzerlandKenya Medical Research InstituteNot yet recruitingVisceral Leishmaniasis
-
Centre Hospitalier Intercommunal CreteilUniversity Hospital, Paris; Hôpital Necker-Enfants Malades; Groupe Hospitalier... and other collaboratorsRecruitingStreptococcal PharyngitisFrance
-
Salem Anaesthesia Pain ClinicRecruiting
-
Juan Fernando Masa JiménezNot yet recruitingSARS-CoV Infection
-
Mach-E B.V.Completed
-
Guangzhou Wondfo Biotech Co., LtdSuspended
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Somerset NHS Foundation TrustUnknown
-
University of British ColumbiaProvidence Health & Services; Vancouver Airport Authority; WestJet Airlines; KLM...Completed
-
Norwegian Institute of Public HealthUniversity of OsloWithdrawn